[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Controversies in Neurology
May 2003

Should the Multicenter Carotid Endarterectomy Trials Be Repeated?

Author Affiliations

From the Department of Neurology, Wayne State University, Detroit, Mich.



Arch Neurol. 2003;60(5):774-775. doi:10.1001/archneur.60.5.774

THE 2 MAJOR clinical trials pertaining to carotid endarterectomy (CE) that were conducted in North America and published in the past decade were landmark clinical achievements. These studies, the North American Symptomatic Carotid Endarterectomy Trial (NASCET)1,2 and the Asymptomatic Carotid Atherosclerosis Study (ACAS),3 brought hard data to a surgical procedure that had been performed for decades but without clear efficacy. The NASCET study found that patients with recently symptomatic 70% to 99% angiographic stenosis had robust benefit from CE, with a 17% absolute difference at 2 years in terms of recurrent ipsilateral stroke compared with medical management.

First Page Preview View Large
First page PDF preview
First page PDF preview